We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

116 hedge funds and large institutions have $1.01B invested in Pacira BioSciences in 2013 Q2 according to their latest regulatory filings, with 116 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

104.37% more ownership

Funds ownership: 0% → 104.37% (+104%)

27% more call options, than puts

Call options by funds: $3.08M | Put options by funds: $2.44M

Holders
116
Holders Change
+116
Holders Change %
–
% of All Funds
3.77%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
116
Increased
–
Reduced
–
Closed
–
Calls
$3.08M
Puts
$2.44M
Net Calls
+$648K
Net Calls Change
+$648K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PCRX Hedge Fund Activity: Q2 2013 in Review

116 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q2 2013, worth a combined $1.01B.

Buyers outnumbered sellers: 116 funds opened new PCRX positions and 0 closed out — a net gain of 116 holders — while 0 added to existing stakes and 0 trimmed.

  • 116 institutional investors held Pacira BioSciences (PCRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.01B of Pacira BioSciences stock for Q2 2013.
  • 116 funds opened new Pacira BioSciences positions in Q2 2013 and 0 closed out, a net change of +116 holders.

Based on aggregated 13F filings for Q2 2013.